Larimar Therapeutics, Inc. (LRMR)
3.83
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
3.85
+0.02
(+0.52%)
After-Hours: 20:00
Larimar Therapeutics Cash from Investing (Quarterly) : -40.91M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -40.91M |
| March 31, 2026 | 29.00M |
| December 31, 2025 | 34.00M |
| September 30, 2025 | 33.02M |
| June 30, 2025 | 18.84M |
| March 31, 2025 | 14.45M |
| December 31, 2024 | 19.20M |
| September 30, 2024 | 27.27M |
| June 30, 2024 | -63.49M |
| March 31, 2024 | -68.36M |
| December 31, 2023 | -2.629M |
| September 30, 2023 | -46.43M |
| June 30, 2023 | -9.838M |
| March 31, 2023 | 92.25M |
| December 31, 2022 | -52.23M |
| September 30, 2022 | -3.384M |
| June 30, 2022 | -35.34M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 6.49M |
| September 30, 2021 | -6.791M |
| June 30, 2021 | 19.22M |
| March 31, 2021 | 5.251M |
| December 31, 2020 | -23.54M |
| September 30, 2020 | -0.008M |
| June 30, 2020 | 41.42M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.778M |
| December 31, 2019 | -0.05M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.84M |
| March 31, 2019 | 0.807M |
| December 31, 2018 | 14.27M |
| September 30, 2018 | -47.44M |
| June 30, 2018 | 8.344M |
| March 31, 2018 | 17.96M |
| December 31, 2017 | 12.69M |
| September 30, 2017 | 0.279M |
| June 30, 2017 | 13.99M |
| March 31, 2017 | 8.691M |
| December 31, 2016 | 16.91M |
| September 30, 2016 | 16.44M |
| June 30, 2016 | 3.82M |
| March 31, 2016 | 14.27M |
| December 31, 2015 | 15.46M |
| September 30, 2015 | -28.51M |
| June 30, 2015 | -9.336M |
| March 31, 2015 | -69.73M |
| December 31, 2014 | -57.22M |
| September 30, 2014 | -0.031M |
| June 30, 2014 | -0.063M |
| March 31, 2014 | -0.005M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 0.00 |
| Marker Therapeutics, Inc. | 0.00 |
| Rezolute, Inc. | 12.28M |
| Krystal Biotech, Inc. | -161.58M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -44.03M |
| Cash from Financing (Quarterly) | -0.435M |
| Free Cash Flow | -156.08M |
| Free Cash Flow Per Share (Quarterly) | -0.4231 |
| Free Cash Flow to Equity (Quarterly) | -45.34M |
| Free Cash Flow to Firm (Quarterly) | -44.16M |
| Free Cash Flow Yield | -45.48% |